focus -WSS

focus

author：comprehensive 2025-09-30 17:27:28 - browse：953

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Apple Watch's A

focus

WSS

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Eisai exec who led development of Alzheimer’s drug to retire

Brain worms: The science behind RFK Jr.'s parasitic infection

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

After gene therapy, two congenitally deaf children hear for the first time

focus

focus

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Shionogi licenses Pompe disease therapy from Maze Therapeutics

At least 13 dead in Texas as scorching temps continue

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

As demand for Covid shots wanes, Moderna seeks its next success

First recipient of genetically engineered pig kidney has died

Activists slam private health insurers over coverage restrictions

Making AI in medicine accessible to smaller, and rural hospitals

Medical records are filled with copy

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

entertainment

Home health providers sue Medicare over payment cuts

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Biden’s NIH nominee is languishing in Congress

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Google says AlphaFold 3 can map a vast universe of biomolecules

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

focus

focus

focus

hotspot